Clinical Trial Update: A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of TERN-701 in adults with chronic myeloid leukemia (ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• TERN-701

Snippet

Sponsor: Terns, Inc. | Conditions: Chronic Myeloid Leukemia, Chronic Phase, Chronic Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING